Link To Webinar, 31 October 2022, page-14

First 14 Last

Share
Profile

Follow
Laup56

4,554 Posts.

533

03/11/22

10:55

Post #: 64564405
Share

Originally posted by FrankieAlfie ↑

So having listened to two of the presentations, I am going to upgrade my position to buy.
The following reasons:
1. the major concern of finance will be mitigated by already having orders and componentry in place. They need to do a production run and they are very coy about the length of time. Normally this coyness would frustrate me but listen to John he takes me as someone who is looking at underpromising and overdelivering!!! I believe that it isn't unreasonable to think that the best buy order would easily be in the vicinity of 3000 at the bottom end. That's 10 units for each brick-and-mortar best buys store or a combination of BM and online. John mentioned that he expects it to be same-day delivery so the stock needs to be there. They expect the stock to be in place this quarter and they have enough componentry for 50000 units.
2. Point 1 does not consider sonova or amazon etc. it may be fair to estimate they could have a similar order.
3. John is impressive. He seems to have a good understanding of the sales angle. This is now the next box to tick. Are the products good enough? Will people buy them? They are unanswered questions. They seem to have the sales channels in place that if they are this could skyrocket.
4. I liked his take on the audiologist's question. Would audiologists work against the sale of these products? No. The customer they are targeting would have actually left the audiologist without buying anything. As such, there is an opportunity for audiologists to make money and in a mutually beneficial relationship, Nuheara would be able to guide those who test for the Pros and find them not sufficient to be directed to an audiologist.
Is it still a risk? Yes very much so. You just don't know if the product is going to sell. However the old risk reward factor is at play. If it does sell they could make 50 000 units which would equate to 30 000 000 in revenue. Those sort of figures would shoot the SP through the roof.
the reward is very much worth the risk.
Still annoyed about the share consolidation literally could have had many millionaires through this stock and now it is potentially life changing but no where near what it could have been,

Expand

In the Investor Briefing from Melbourne this morning, John Luna stated they have received LARGE orders from all of the existing retail partners, which now also includes Fuel Medical ENT/ Audiological with 3,000 POS.

NUH Price at posting: 28.0¢ Sentiment: Buy Disclosure: Held
17 Upvote

0 Great analysis

Reply

Top Stories

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

LU7

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

REA

UK-based Rightmove knocks back REA Group's acquisition proposal

PIQ

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

MAY

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

There are more pages in this discussion • 10 more messages in this thread...

First 14 Last

Add NUH (ASX) to my watchlist

(20min delay)
Last 8.1¢		Change 0.000(0.00%)		Mkt cap ! $21.91M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Link To Webinar, 31 October 2022, page-14

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

UK-based Rightmove knocks back REA Group's acquisition proposal

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

Featured News

Featured News

Link To Webinar, 31 October 2022, page-14

Top Stories

S&P 500 futures dip during non-deciding Trump-Harris Debate; bullish for energy

Lithium Universe 'dream team' ready to step into the demand-supply breach in Canada

UK-based Rightmove knocks back REA Group's acquisition proposal

Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test

HotCopper users liking Melbana Energy's news it's becoming an oil producer; shares jump +47%

Featured News

Featured News